4,175
Views
0
CrossRef citations to date
0
Altmetric
Clinical focus: Diabetes - Practice Pearl

Linagliptin in patients with type 2 diabetes and cardiovascular and/or renal disease: results from a cardiovascular and renal outcomes trial

Pages 314-319 | Received 23 Oct 2019, Accepted 11 Mar 2020, Published online: 20 Mar 2020

Figures & data

Table 1. Summary of CVOTs of DPP4 inhibitors in patients with T2DM.